| dc.description.abstract |
ABSTRACT
Objectives The COVID-19 pandemic threatened global HIV
Test and Treat Efforts. We assessed whether it affected (1)
the number of antiretroviral therapy (ART) initiations and
(2) the proportion of timely ART initiations in people living
with HIV (PLWH) globally.
Design Quasi-experimental, regression discontinuity
design using routinely collected data from HIV clinics.
Setting 360 HIV care clinics across primary and
secondary levels of care, participating in the International
epidemiology Databases to Evaluate AIDS consortium, in
31 countries in Asia, Africa and the Americas.
Participants 177 391 PLWH (≥18 years old) who initiated
ART 2 years before and 1 year after the onset of the
COVID-19 pandemic in their country.
Primary and secondary outcome measures The
primary outcome was the number of ART initiations per
week; the secondary outcome was the proportion of
timely ART initiations (ie, ART initiated within 7 days of
enrolment). We assessed changes in these outcomes in
the 52 weeks after compared to the 104 weeks before the
pandemic onset, defined using each country’s peak Oxford
Stringency Index score between January and June 2020.
Results Among 177 391 newly enrolled PLWH, 129 743
initiated during the pre-pandemic and 47 648 post-
pandemic onset. 72.5% of ART initiations were timely
pre-pandemic whereas 82.3% were during the pandemic.
Absolute number of ART initiations remained stable during
the pandemic period in 25 of 31 countries but decreased
significantly in six countries: India (−5.0 p, 95% CI −9.2 to
−0.7), Rwanda (−10.0 p, −18.6 to −1.4), Malawi (−33.4 p,
−54.1 to −12.3), South Africa (−130.8 p, −188.6 to −73.1),
Zimbabwe (−12.9 p, −20.0 to −5.8) and Togo (−19.6 p,
−39.1 to −0.1). The proportion of timely initiations was
stable in all countries except in Kenya (+4.2 pp, 95% CI
+0.3 to +8.1) and in Mozambique (+2.7 pp, +0.5 to +4.9),
where it increased significantlyConclusions A deeper understanding of the factors that
contributed to sustaining ART initiations, particularly in
settings with stringent public health and social measures,
is needed. These insights should inform preparedness
strategies, resource allocation and policy development toensure continuity of HIV services during future health emergencies, in line
with World Health Organisation recommendations |
en_US |